Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M De Castro Julve"'
Autor:
T Rovira, M de Castro Julve, T Gili Bigatà, G Gómez Llanes, Y Campos García, G Molas Ferrer, B López García, M Gómez-Valent
Publikováno v:
Section 7: Post Congress additions.
Publikováno v:
Patient safety and risk management.
Background Identifying the risk factors in patients that are more susceptible to drug related problems (DRPs) promotes closer pharmacotherapy monitoring that prevents morbidity–mortality in these patients. Purpose To develop a predictive model of h
Publikováno v:
European Journal of Hospital Pharmacy. 23:A80.2-A81
Background Hospital pharmacists validate many treatments per day, mostly not knowing the hospitalised patient’s current situation and with little interaction with the medical team and nurses who care for these patients. Purpose To describe differen
Autor:
M. García Argelaguet, MQ Gorgas Torner, L Borràs Trias, L Raich Montiu, C. Pontes García, M De Castro Julve
Publikováno v:
European Journal of Hospital Pharmacy. 22:A108.2-A109
Background It has been repeatedly reported that up to 7% of patients have serious adverse drug reactions (ADR) during hospital admissions. Hospital-based pharmacovigilance aims to detect previously unknown serious ADRs arising during differential dia
Autor:
MQ Gorgas Torner, L Ortiz Ruiz, A Estefanell Tejero, E Oliver Ferrer, L Borràs Trias, C. Pontes García, N Rudi Sola, L Raich Montiu, M De Castro Julve
Publikováno v:
European Journal of Hospital Pharmacy. 22:A109.1-A109
Background Tenofovir/emtricitabine/rilpivirine (TDF/FTC/RPV) is a recently-marketed fixed-dose combination of antiretrovirals with which there is little clinical experience as yet. Purpose To describe our clinical experience with TDF/FTC/RPV, in term
Autor:
Milagros García-Peláez, MQ Gorgas Torner, M. Cabré Serres, L Borràs Trias, M Gómez-Valent, L Raich Montiu, ML Iglesias Lepine, M De Castro Julve, M Payés Peich
Publikováno v:
European Journal of Hospital Pharmacy. 21:A145.2-A145
Background Clinical safety is an essential component of health care quality. The EVADUR study showed that 12% of patients who were in the emergency department (ED) had adverse events (AE). 70% of them were considered avoidable. Purpose To describe ph
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hernández Peláez L; Unidad de Atención al Paciente Crónico Complejo y Paliativo Pediátrico, Servicio de Pediatría, Parc Taulí Hospital Universitari, Sabadell, España. Electronic address: luciahdezpelaez@gmail.com., Serna Berná JV; Unidad de Atención al Paciente Crónico Complejo y Paliativo Pediátrico, Servicio de Pediatría, Parc Taulí Hospital Universitari, Sabadell, España., de Castro Julve M; Servicio de Farmacia, Parc Taulí Hospital Universitari, Sabadell, España., Pérez Contel A; Servicio de Farmacia, Parc Taulí Hospital Universitari, Sabadell, España.
Publikováno v:
Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria [Farm Hosp] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.